Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

FSD Pharma Inc C.HUGE

Alternate Symbol(s):  HUGE

FSD Pharma Inc. is a Canada-based biotechnology company. The Company operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial real estate property. Lucid-PSYCH is a molecular compound identified for the potential treatment of mental health disorders. Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders. UNBUZZD is a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of potentially quickly relieving from the effects of alcohol consumption, such as inebriation, and restoring normal lifestyle.


CSE:HUGE - Post by User

Comment by Bigmac4000on Sep 26, 2020 7:25am
95 Views
Post# 31624934

RE:RE:RE:RE:Misrepresentation of Facts

RE:RE:RE:RE:Misrepresentation of FactsOh man those quotes from several of them over the years are amazing. Absolutely absurd but amazing. The fake valuations they gave FSD and future FSD valuations was beyond laughable. Every now and then they pop up with some defense for FSD and what they are doing currently and some excuse for why they are broke or way way behind. The FSD Facebook videos with AD are a joke. The things Anthony said to get people excited were completely fabricated. I could see this whole story being told one day in a made for tv movie. "The rise and quick fall of FSD and the millions they took with them"
GrahamB wrote:
mousetrap1 wrote: I think my example of income is exactly the same as your estimate of expenses. FSD has prided itself in being debt free and I don't see that changing. Their expenses will rise as income streams increase.... accordingly and debt free. I look forward to discussing this after a couple of quarters have past. GLTA longs!!...........................................................................................


GrahamB wrote:
Mousetrap1: ." Let's say, just for conversation's sake that FSD sold it's Cobourg facility for $15 million. Would you assume that this 15 million should be added to every quarter going forward because this is now factual history and indicates a trend? NO!!!! you would not." 
 
  You are making an example, that does not relate to the facts, and extending it inappropriately to make a point.
 
The question should be, what are the typical expenses, that can be reasonably expected to continue into the future.
 
If they are spending money on salaries, electricity for the building, insurance, consulting fees which are contractionally obligated, advertsing, clinical trials.... 

One can estimate that some of these costs will extend
 
If you add these expenses up, which are basic overhead you will see that it will amount to several million dollars each quarter.
 
Granted, there were some exceptional expenses, and we hope that those will not be duplicated.  Still, you know that they are going to have to spend millions of dollars on clinical trials, and that that process itself is going to be expensive.
 
So, if you really do not believe that they will be spending millions of dollars each quarter, once they are conducting operations in earnest, I believe you are either being nave or disingenuous.
 
I think we can leave this conversation to rest, but let us see what the financials are over the next 6-12 months.
 
I estimate that they will be at least 2-3  million a quarter, and likely will approach 10-15 million annually. The revenue, I believe from operations will not equal this, and I believe they will need to do financings and sghare dilutions to continue.
 
You think they will be able to operate for a year at 5 million, if I understand you correctly.
 
So let us just wait and see.
 
I will save this post, as I saved the last post from October, in which you recommended people support the stock at around $0.60, and buy more. 
 
Anyone who followed that advice, and that of Niet, would have clear evidence, with which they might suspect your accuracy, and skill. 




Hi Mouse,
'Just following up on our thread now that we have financials updated and new ones coming.
Care to review?



<< Previous
Bullboard Posts
Next >>